Cardinal Strategic Wealth Guidance’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cardinal Strategic Wealth Guidance's LLY Position: Q2 2026 in Review
Cardinal Strategic Wealth Guidance reduced its Eli Lilly (LLY) stake by 2.6% in Q2 2026, selling an estimated $13.3K and leaving 481 shares worth $577K. The position accounts for 0.13% of the portfolio, ranked #37.
Cardinal Strategic Wealth Guidance first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. The position peaked at $603K in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Cardinal Strategic Wealth Guidance held 481 shares of Eli Lilly worth $577K as of Q2 2026.
- Cardinal Strategic Wealth Guidance sold 13 Eli Lilly shares in Q2 2026, an estimated $13.3K.
- Eli Lilly made up 0.13% of Cardinal Strategic Wealth Guidance's portfolio in Q2 2026, its #37 holding.
- Cardinal Strategic Wealth Guidance first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
- Cardinal Strategic Wealth Guidance's Eli Lilly position peaked at $603K in Q4 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Cardinal Strategic Wealth Guidance's 13F filing for Q2 2026, filed 30 Jul 2026.